정맥내 수액백 시장 규모, 점유율, 성장 분석(용량별, 최종사용자별, 용도별, 재료별, 지역별) : 산업 예측(2025-2032년)

Global Intravenous IV Fluid Bags Market size was valued at USD 3.4 billion in 2023 and is poised to grow from USD 3.64 billion in 2024 to USD 6.3 billion by 2032, growing at a CAGR of 7.1% during the forecast period (2025-2032).

The medical fluid bag market is witnessing significant growth, driven by innovations and a rising preference for disposable IV fluid bags to mitigate hospital-acquired infections and cross-contamination. Designed with an interior pouch and outer plastic coating, these versatile bags ensure the safe storage of blood samples, medications, and fluids, thereby enhancing sterilization processes. They play a critical role in fluid replacement therapy, blood transfusions, and maintaining electrolyte balance, which is vital for patient health. Moreover, the increasing adoption of PVC-free and non-latex bags highlights the industry's shift towards safer alternatives. As healthcare facilities prioritize infection control while striving to reduce costs, the demand for these advanced fluid bags is expected to grow considerably in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intravenous Iv Fluid Bags market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intravenous Iv Fluid Bags Market Segmental Analysis

Global Intravenous IV Fluid Bags Market is segmented by Capacity, End User, Application, Material and region. Based on Capacity, the market is segmented into < 250 ml, 250 to 500 ml and > 500 ml. Based on End User, the market is segmented into Hospitals and Clinics, Ambulatory Surgical Centres and Homecare Settings. Based on Application, the market is segmented into Fluid Replacement, Medication Administration and Blood Transfusion. Based on Material, the market is segmented into PVC and Non-PVC. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Intravenous Iv Fluid Bags Market

The global intravenous (IV) fluid bags market is significantly driven by the increasing aging population, which contributes to a rise in various health conditions necessitating advanced treatment methodologies. As individuals age, they often experience a higher prevalence of chronic illnesses that require prompt and efficient medication delivery systems. Intravenous administration is favored over oral methods due to its rapid and precise outcomes, leading to greater patient satisfaction and improved health results. Furthermore, heightened awareness among consumers regarding the benefits of IV fluid administration is anticipated to bolster market growth throughout the forecast period, underscoring the vital role these products play in modern healthcare provision.

Restraints in the Global Intravenous Iv Fluid Bags Market

The Global Intravenous IV Fluid Bags market faces significant restraints due to several pressing concerns. Authorities are increasingly apprehensive about the risk of infections and vein collapse associated with prolonged use of needles, which could adversely affect market growth. Additionally, the potential for nutrient imbalances resulting from suboptimal monitoring of intravenous therapies presents another challenge. Furthermore, alternative solutions such as plastic and glass bottles, as well as infusion pumps, offer competition to traditional IV fluid bags, potentially diminishing demand. Moreover, standard 1-liter IV bags pose risks when used in pediatric care, as children should not be exposed to such large volumes of electrolyte solutions.

Market Trends of the Global Intravenous Iv Fluid Bags Market

The Global Intravenous IV Fluid Bags market is witnessing a robust growth trend driven by the rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular conditions, particularly among the aging population. Additionally, an increase in gastrointestinal disorders is propelling demand for IV fluid bags. However, concerns over the environmental impact and health risks associated with PVC-based medical fluid bags may pose challenges to market expansion. Despite these hurdles, the global expansion of healthcare facilities and an increased focus on patient care is significantly enhancing the adoption of intravenous fluid bags, ensuring continual market growth in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global Intravenous IV Fluid Bags Market Size by Capacity & CAGR (2025-2032)

• Market Overview
• < 250 ml
• 250 to 500 ml
• 500 ml

Global Intravenous IV Fluid Bags Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Ambulatory Surgical Centres
• Homecare Settings

Global Intravenous IV Fluid Bags Market Size by Application & CAGR (2025-2032)

• Market Overview
• Fluid Replacement
• Medication Administration
• Blood Transfusion

Global Intravenous IV Fluid Bags Market Size by Material & CAGR (2025-2032)

• Market Overview
• PVC
• Non-PVC

Global Intravenous IV Fluid Bags Market Size & CAGR (2025-2032)

• North America (Capacity, End User, Application, Material)
  • US
  • Canada
• Europe (Capacity, End User, Application, Material)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Capacity, End User, Application, Material)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Capacity, End User, Application, Material)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Capacity, End User, Application, Material)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JW Life Science Corp. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amcor plc (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Technoflex (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sippex (Germany) (A MEDIPPEX Co.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Polycine GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka Pharmaceutical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smiths Medical (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemotronic S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedicoPack A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kraton Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PolyCine GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fosmo Med (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations